Overview
Updated 14 Jul 2026
Dana V. Rizk is Anupam Agarwal Endowed Professor of Medicine at University of Alabama at Birmingham (UAB) Heersink School of Medicine, Division of Nephrology. The public record shows 180 publications with 4,764 citations (h-index 34), centered on Chronic Kidney Disease. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · Nephrology, dialysis, transplantation
- Top research focus: Chronic Kidney Disease
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Public positionssourced statements on record
- Site Principal Investigator
phase 3 APPLAUSE-IgAN trial of iptacopan (Fabhalta) in IgA nephropathy, published in NEJM
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Sponsor: Takeda
InvestigatorPhase 3RecruitingNCT06963827 - FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.
Sponsor: FAST BioMedical
InvestigatorCompletedNCT01978314
Industry payments
Updated 14 Jul 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year202517 payments$29,517openpaymentsdata.cms.gov ↗
- Travere Therapeutics, Inc.Program year202511 payments$15,242openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20253 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
Nephrology, dialysis, transplantation
2026 - Targeting APRIL in the Treatment of IgA Nephropathy.
Clinical journal of the American Society of Nephrology
2024
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
2000 6th Avenue South, Floor 4, Birmingham, AL 35233
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
- Board certified in Nephrology
American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Residency (including chief residency) and Nephrology Fellowship
Emory University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
Editorial & leadership rolesjournal and society appointments
- "WIN Faculty" (Women in Nephrology) designation
American Society of Nephrology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - Member
The Southern Society for Clinical Investigation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ssciweb.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nephcure.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
Secondary affiliationsappointments beyond the home institution
- Director
Clinical Trials Research, Division of Nephrology, UAB
- Medical Director
UAB Glomerular Kidney Disease Clinic (Kirklin Clinic)
- Medical Director
Clinical Trials Administrative Office, UAB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajkdblog.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- Medscape InDiscussion podcast series episode with Matthew A. Sparks on IgA nephropathy pathology
presentation, and management (S2 Ep. 3, "Does Your Patient Have IgA Nephropathy?")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/dana-rizk-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
kdigo.org/full-kdigo-2025-igan-podcast-series-now-available
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kdigo.org ↗ - Other
asn-online.org/about/bio.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - Orcid.org
X (Twitter) handle @DanaRizk1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Toni Choueiri, MD
Brigham and Women's Hospital
- 2,494
- publications
- 152
- h-index
- 12
- trials
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
- 1,588
- publications
- 150
- h-index
- 18
- trials
Fred Saad, MD
Centre Hospitalier de l’Université de Montréal
- 1,915
- publications
- 128
- h-index
- 7
- trials